Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
0.3793
-0.0107 (-2.74%)
At close: Apr 1, 2025, 4:00 PM
0.3778
-0.0015 (-0.39%)
After-hours: Apr 1, 2025, 7:55 PM EDT

Acurx Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Net Income
-14.1-14.58-12.09-12.75-4.6
Upgrade
Stock-Based Compensation
3.443.773.36.071.48
Upgrade
Other Operating Activities
---1.520.57
Upgrade
Change in Accounts Payable
0.20.981.220.39-0.8
Upgrade
Change in Other Net Operating Assets
0.080.030.03-0.25-0
Upgrade
Operating Cash Flow
-10.38-9.8-7.54-5.01-3.35
Upgrade
Long-Term Debt Issued
----0.07
Upgrade
Net Debt Issued (Repaid)
----0.07
Upgrade
Issuance of Common Stock
6.628.163.714.83.98
Upgrade
Financing Cash Flow
6.628.163.714.84.04
Upgrade
Net Cash Flow
-3.77-1.64-3.859.780.69
Upgrade
Levered Free Cash Flow
-5.09-4.33-3.01-0.21-2.08
Upgrade
Unlevered Free Cash Flow
-5.09-4.33-3.01-0.21-2.08
Upgrade
Change in Net Working Capital
-0.28-1.01-1.25-0.141.26
Upgrade
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q